These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3322423)

  • 1. Decreased insulin binding and antilipolytic response in adipocytes from patients with Cushing's syndrome.
    Calle C; Carranza MC; Simón MA; Torres A; Mayor P
    Biosci Rep; 1987 Sep; 7(9):713-9. PubMed ID: 3322423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic and endogenous regulation of insulin receptors by catecholamines in adipocytes from patients with a phaeochromocytoma.
    Carranza MC; Simón MA; Torres A; Calle C
    Biosci Rep; 1990 Apr; 10(2):201-7. PubMed ID: 2192764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding and antilipolytic action of insulin in isolated adipocytes from cortisol-treated rats.
    Calle C; Sánchez-Casas P; Carranza MC; Simon MA; Mayor P
    Rev Esp Fisiol; 1988 Sep; 44(3):309-14. PubMed ID: 3068737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle and adipose tissue morphology and metabolism in Cushing's syndrome.
    Rebuffé-Scrive M; Krotkiewski M; Elfverson J; Björntorp P
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1122-8. PubMed ID: 3142910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical investigation on the mechanism of glucose intolerance in Cushing's syndrome].
    Takeda N; Yasuda K; Horiya T; Yamada H; Imai T; Kitada M; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1986 May; 62(5):631-48. PubMed ID: 3525245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of long-term nickel ingestion on insulin binding and antilipolytic response in rat adipocytes.
    Mayor P; Cabrera R; Ribas B; Calle C
    Biol Trace Elem Res; 1989 Oct; 22(1):63-70. PubMed ID: 2484229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation among body composition and metabolic regulation in a male mouse model of Cushing's syndrome.
    Uehara M; Yamazaki H; Yoshikawa N; Kuribara-Souta A; Tanaka H
    Endocr J; 2020 Jan; 67(1):21-30. PubMed ID: 31495810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin receptor mRNA levels are modulated in a tissue-specific manner in Cushing's syndrome patients.
    Leal MA; Aller P; Torres A; Picardo A; Dávila N; Calle C
    Horm Metab Res; 1994 Jul; 26(7):349-50. PubMed ID: 7959613
    [No Abstract]   [Full Text] [Related]  

  • 9. Glucose metabolism in Cushing's syndrome.
    Sharma A; Vella A
    Curr Opin Endocrinol Diabetes Obes; 2020 Jun; 27(3):140-145. PubMed ID: 32250974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of the insulin receptors of adipocyte plasma membranes in hypercorticism].
    Komissarenko VP; Bezdrobnyĭ IuV; Evdokimova NIu; Komissarenko IV; Efimov AS
    Dokl Akad Nauk SSSR; 1979; 244(2):474-8. PubMed ID: 421656
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of glucocorticoid on 125I-insulin binding to human erythrocytes. Possible postreceptor modulation of receptor binding.
    Lee KU; Kim SY; Lee HK; Min HK
    Diabetes Res Clin Pract; 1985 Dec; 1(4):211-20. PubMed ID: 3915263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does central obesity reflect "Cushing's disease of the omentum"?
    Bujalska IJ; Kumar S; Stewart PM
    Lancet; 1997 Apr; 349(9060):1210-3. PubMed ID: 9130942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasma leptin levels in relation to body composition and body fat distribution in patients with Cushing's syndrome].
    Robaczyk M; Krzyzanowiska-Swiniarska B; Andrysiak-Mamos E; Kulig G; Pilarska K
    Pol Arch Med Wewn; 2003 Nov; 110(5):1299-308. PubMed ID: 16737000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggerated corticotropin and cortisol responses.
    Leal-Cerro A; Torres E; Soto A; Dios E; Deghenghi R; Arvat E; Ghigo E; Dieguez C; Casanueva FF
    Neuroendocrinology; 2002 Dec; 76(6):390-6. PubMed ID: 12566947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance in Cushing's disease. Evaluation by studies of insulin binding to erythrocytes.
    Wajchenberg BL; Leme CE; Lerario AC; Toledo e Souza IT; Rodbard HW; Rodbard D
    Diabetes; 1984 May; 33(5):455-9. PubMed ID: 6373454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of dyslipidemia in Cushing's syndrome.
    Arnaldi G; Scandali VM; Trementino L; Cardinaletti M; Appolloni G; Boscaro M
    Neuroendocrinology; 2010; 92 Suppl 1():86-90. PubMed ID: 20829625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC; Raff H; Findling JW
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes.
    Yaneva M; Mosnier-Pudar H; Dugué MA; Grabar S; Fulla Y; Bertagna X
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3345-51. PubMed ID: 15240613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.